Advertisement

FPRX

Five Prime Therapeutics, Inc.

Set alert

Price alert · FPRX

All alert types
— — —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
1.77B
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-18.45
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
May 6, 2021
50-d avg
37.83
200-d avg
20.74
1y target
37.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for FPRX has not been loaded yet. Try again in a moment.

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
RA Capital Management, L.P.9.20%4,285,16172.89MDec 30, 2020
Blackrock Inc.6.35%2,959,03150.33MDec 30, 2020
RTW Investments LP5.40%2,515,78842.79MDec 30, 2020
Vanguard Group, Inc. (The)4.45%2,070,72735.22MDec 30, 2020
Price (T.Rowe) Associates Inc3.65%1,697,65928.88MDec 30, 2020
Invesco Ltd.3.60%1,677,38228.53MDec 30, 2020

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF2.80%1,302,28749.06MMar 30, 2021
Vanguard Total Stock Market Index Fund2.42%1,128,42519.19MDec 30, 2020
iShares Russell 2000 ETF1.65%768,50728.95MMar 30, 2021
Price (T.Rowe) New Horizons Fund1.53%714,69112.16MDec 30, 2020
Vanguard Extended Market Index Fund1.35%626,41010.66MDec 30, 2020
Fidelity Select Portfolios - Biotechnology1.29%603,03513.41MFeb 27, 2021
FPRX insiders
InsiderRelationLatest transactionDateShares held
BERGER FRANKLIN MDirectorSaleDec 2, 20195,000
BVF PARTNERS L PBeneficial Owner of more than 10% of a Class of SecuritySaleNov 10, 20200
CIVIK THOMASChief Executive OfficerStock Award(Grant)Apr 12, 202075,000
COLLINS HELEN LOUISE M.D.OfficerStock Award(Grant)Apr 15, 20210
KNICKERBOCKER ARON MARC MBAChief Executive OfficerConversion of Exercise of derivative securityJun 6, 20190
RINGO WILLIAM R JRDirectorStock GiftApr 4, 20210
Advertisement